Efficacia e tollerabilità del valproato chrono nelle epilessie a esordio in età pediatrica

Studio multicentrico

Translated title of the contribution: Efficacy and safety of sustained-release valproate in paediatric onset epilepsies: A multi-centre study

A. Montagninì, F. Beccarìa, A. Romeo, P. Veggiottì, M. Vìri, E. Alfeì, G. Capovilla

Research output: Contribution to journalArticle

Abstract

We retrospectively studied all patients referred to three Epilepsy Centres affected by epilepsy occurring in paediatric age and selected 92 patients assuming sustained-release valproate. Our findings underline that VPA, even in extended release form, has good efficacy and safety. In some patients (poor compliance, childhood, adolescents) the single administration improves quality of life.

Original languageItalian
Pages (from-to)211-213
Number of pages3
JournalBollettino - Lega Italiana contro l'Epilessia
Issue number121-122
Publication statusPublished - Jul 2003

Fingerprint

Valproic Acid
Epilepsy
Pediatrics
Safety
Patient Compliance
Quality of Life

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Montagninì, A., Beccarìa, F., Romeo, A., Veggiottì, P., Vìri, M., Alfeì, E., & Capovilla, G. (2003). Efficacia e tollerabilità del valproato chrono nelle epilessie a esordio in età pediatrica: Studio multicentrico. Bollettino - Lega Italiana contro l'Epilessia, (121-122), 211-213.

Efficacia e tollerabilità del valproato chrono nelle epilessie a esordio in età pediatrica : Studio multicentrico. / Montagninì, A.; Beccarìa, F.; Romeo, A.; Veggiottì, P.; Vìri, M.; Alfeì, E.; Capovilla, G.

In: Bollettino - Lega Italiana contro l'Epilessia, No. 121-122, 07.2003, p. 211-213.

Research output: Contribution to journalArticle

Montagninì, A, Beccarìa, F, Romeo, A, Veggiottì, P, Vìri, M, Alfeì, E & Capovilla, G 2003, 'Efficacia e tollerabilità del valproato chrono nelle epilessie a esordio in età pediatrica: Studio multicentrico', Bollettino - Lega Italiana contro l'Epilessia, no. 121-122, pp. 211-213.
Montagninì A, Beccarìa F, Romeo A, Veggiottì P, Vìri M, Alfeì E et al. Efficacia e tollerabilità del valproato chrono nelle epilessie a esordio in età pediatrica: Studio multicentrico. Bollettino - Lega Italiana contro l'Epilessia. 2003 Jul;(121-122):211-213.
Montagninì, A. ; Beccarìa, F. ; Romeo, A. ; Veggiottì, P. ; Vìri, M. ; Alfeì, E. ; Capovilla, G. / Efficacia e tollerabilità del valproato chrono nelle epilessie a esordio in età pediatrica : Studio multicentrico. In: Bollettino - Lega Italiana contro l'Epilessia. 2003 ; No. 121-122. pp. 211-213.
@article{10eb3e1c46664b409ed82f270f073a01,
title = "Efficacia e tollerabilit{\`a} del valproato chrono nelle epilessie a esordio in et{\`a} pediatrica: Studio multicentrico",
abstract = "We retrospectively studied all patients referred to three Epilepsy Centres affected by epilepsy occurring in paediatric age and selected 92 patients assuming sustained-release valproate. Our findings underline that VPA, even in extended release form, has good efficacy and safety. In some patients (poor compliance, childhood, adolescents) the single administration improves quality of life.",
keywords = "Divalproex, Epilepsy, Sustained-Release",
author = "A. Montagnin{\`i} and F. Beccar{\`i}a and A. Romeo and P. Veggiott{\`i} and M. V{\`i}ri and E. Alfe{\`i} and G. Capovilla",
year = "2003",
month = "7",
language = "Italian",
pages = "211--213",
journal = "Bollettino - Lega Italiana contro l'Epilessia",
issn = "0394-560X",
publisher = "Lega Italiana contro l'Epilessia",
number = "121-122",

}

TY - JOUR

T1 - Efficacia e tollerabilità del valproato chrono nelle epilessie a esordio in età pediatrica

T2 - Studio multicentrico

AU - Montagninì, A.

AU - Beccarìa, F.

AU - Romeo, A.

AU - Veggiottì, P.

AU - Vìri, M.

AU - Alfeì, E.

AU - Capovilla, G.

PY - 2003/7

Y1 - 2003/7

N2 - We retrospectively studied all patients referred to three Epilepsy Centres affected by epilepsy occurring in paediatric age and selected 92 patients assuming sustained-release valproate. Our findings underline that VPA, even in extended release form, has good efficacy and safety. In some patients (poor compliance, childhood, adolescents) the single administration improves quality of life.

AB - We retrospectively studied all patients referred to three Epilepsy Centres affected by epilepsy occurring in paediatric age and selected 92 patients assuming sustained-release valproate. Our findings underline that VPA, even in extended release form, has good efficacy and safety. In some patients (poor compliance, childhood, adolescents) the single administration improves quality of life.

KW - Divalproex

KW - Epilepsy

KW - Sustained-Release

UR - http://www.scopus.com/inward/record.url?scp=1242272727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1242272727&partnerID=8YFLogxK

M3 - Articolo

SP - 211

EP - 213

JO - Bollettino - Lega Italiana contro l'Epilessia

JF - Bollettino - Lega Italiana contro l'Epilessia

SN - 0394-560X

IS - 121-122

ER -